Lars Vilén
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Acute Myocardial Infarction Research 4
- Genetics 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Co-authors
- Jack Kutti (13 shared papers)Hans Wadenvik (4 shared papers)Börje Ridell (2 shared papers)Hans Wedel (2 shared papers)Peter Johansson (2 shared papers)Soodabeh Safai‐Kutti (2 shared papers)Per Lundborg (3 shared papers)Björn Andréasson (2 shared papers)
- Journals
- Thrombosis and Haemostasis (2 papers)Journal of Internal Medicine (2 papers)British Journal of Haematology (1 paper)Acta Haematologica (1 paper)Blood (1 paper)
- Partner nations
- SwedenNorwayUnited Kingdom
In The Last Decade
Lars Vilén
17 papers receiving 241 citations
Peers
Comparison fields: 5 of 47
- Genetics 135
- Hematology 131
- Internal Medicine 11
- Rheumatology 48
- Cardiology and Cardiovascular Medicine 51
Countries citing papers authored by Lars Vilén
This map shows the geographic impact of Lars Vilén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Vilén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Vilén more than expected).
Fields of papers citing papers by Lars Vilén
This network shows the impact of papers produced by Lars Vilén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Vilén. The network helps show where Lars Vilén may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Vilén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 54 | |
| 2 | 1991 | 40 | |
| 3 | 2000 | 30 | |
| 4 | 1978 | 23 | |
| 5 | 1989 | 18 | |
| 6 | 2002 | 18 | |
| 7 | 1992 | 15 | |
| 8 | 1985 | 12 | |
| 9 | 1983 | 12 | |
| 10 | 1980 | 11 | |
| 11 | 1985 | 11 | |
| 12 | Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group. | 1996 | 9 |
| 13 | 1985 | 8 | |
| 14 | 2002 | 7 | |
| 15 | 1979 | 3 | |
| 16 | 2009 | 2 | |
| 17 | 1986 | 1 |
About Lars Vilén
Lars Vilén is a scholar working on Cardiology and Cardiovascular Medicine, Genetics, Hematology, Analytical Chemistry and Pharmacology, having authored 17 papers that have together received 274 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Acute Myocardial Infarction Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Medication Adherence and Compliance (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Genetics (135 citations), Hematology (131 citations), Internal Medicine (11 citations), Rheumatology (48 citations) and Cardiology and Cardiovascular Medicine (51 citations). Lars Vilén has collaborated with scholars based in Sweden, Norway and United Kingdom. Frequent co-authors include Jack Kutti, Hans Wadenvik, Börje Ridell, Hans Wedel, Peter Johansson, Soodabeh Safai‐Kutti, Per Lundborg, Björn Andréasson, Jan Carneskog and Jan Westin. Their work appears in journals such as Thrombosis and Haemostasis, Journal of Internal Medicine, British Journal of Haematology, Acta Haematologica and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.